![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-5576|11|1|85-102
ISSN: 1568-0096
Source: Current Cancer Drug Targets, Vol.11, Iss.1, 2011-01, pp. : 85-102
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cancer vaccines entering Phase III clinical trials
Expert Opinion on Emerging Drugs, Vol. 8, Iss. 2, 2003-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Clinical Pharmacokinetics, Vol. 49, Iss. 5, 2010-05 ,pp. :